0RB9

Stallergenes Greer (0RB9)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RB9
DataOraFonteTitoloSimboloCompagnia
16/05/201913:00UK RegulatoryStallergenes Greer plc Recommended Cash Acquisition of Stallergenes Greer plc by Ares Life Sciences I S.à r.l.LSE:0RB9Stallergenes Greer Plc
12/12/201817:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Confirms Appointments to the Board of DirectorsLSE:0RB9Stallergenes Greer Plc
20/11/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet ...LSE:0RB9Stallergenes Greer Plc
14/11/201808:00UK RegulatoryStallergenes Greer plc Regulatory ApprovalLSE:0RB9Stallergenes Greer Plc
30/08/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 20...LSE:0RB9Stallergenes Greer Plc
16/08/201808:00UK RegulatoryStallergenes Greer plc Notice of ResultsLSE:0RB9Stallergenes Greer Plc
07/06/201818:30UK RegulatoryStallergenes Greer plc Result of AGMLSE:0RB9Stallergenes Greer Plc
07/06/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Provides Business Update and Refines Its 2018 Financial OutlookLSE:0RB9Stallergenes Greer Plc
29/05/201813:30UK RegulatoryStallergenes Greer plc Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Alle...LSE:0RB9Stallergenes Greer Plc
23/04/201808:00UK RegulatoryStallergenes Greer plc Notice of AGMLSE:0RB9Stallergenes Greer Plc
16/04/201808:00UK RegulatoryStallergenes Greer plc Annual Financial ReportLSE:0RB9Stallergenes Greer Plc
22/03/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Reports Solid Growth and Continued Recovery in 2017, Delivering on Full Year GuidanceLSE:0RB9Stallergenes Greer Plc
15/03/201818:31UK RegulatoryStallergenes Greer plc Stallergenes Greer to Report Full Year Financial Results on 22 March 2018LSE:0RB9Stallergenes Greer Plc
16/02/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Announces Approval in Japan of Pediatric Use for ACTAIR®, Sublingual Immunotherapy...LSE:0RB9Stallergenes Greer Plc
26/01/201808:00UK RegulatoryStallergenes Greer plc Stallergenes Greer Comments on Share Price MovementLSE:0RB9Stallergenes Greer Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RB9
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network